An open-label trial of bromocriptine in nonfluent aphasia
Sabe, L.; Leiguarda, R.; Starkstein, S.E.
Neurology 42(8): 1637-1638
1992
ISSN/ISBN: 0028-3878 PMID: 1641168 Document Number: 395651
Document emailed within 1 workday
Related Documents
Meltzer-Brody, S.E.; Zolnoun, D.; Steege, J.F.; Rinaldi, K.L.; Leserman, J. 2009: Open-label trial of lamotrigine focusing on efficacy in vulvodynia Journal of Reproductive Medicine 54(3): 171-178Wei, J.C.-C.; Chan, T.W.; Lin, H.-S.; Huang, F.; Chou, C.-T. 2003: Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trial Journal of Rheumatology 30(12): 2627-2631
Loo, C.Y.; Tan, H.J.; Teh, H.S.; Raymond, A.A. 2007: Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine Singapore Medical Journal 48(9): 834-839
Seidman, L.; Kroll, R.; Howard, B.; Ricciotti, N.; Hsieh, J.; Weiss, H. 2015: Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial Contraception 91(6): 495-502
Boen, M.; Alhaddad, M.; Guiha, I.; Wu, D.P.; Goldman, M.P. 2018: A Single Site, Open Label Clinical Trial, Evaluating the Duration, Efficacy, and Safety of a Novel Lip Plumper Journal of Drugs in Dermatology: Jdd 17(9): 999-1004
Jolley, D.J.; Wright, R.; McGowan, S.; Hickey, M.B.; Campbell, D.A.; Sinclair, R.D.; Montgomery, K.C. 2004: Preventing pressure ulcers with the Australian Medical Sheepskin: an open-label randomised controlled trial Medical Journal of Australia 180(7): 324-327
Cheema, A.; Aziz, T.; Mirza, S.A.; Siddiqi, A.; Maheshwary, N.; Khan, M.A. 2012: Sodium hyaluronate eye drops in the treatment of dry eye disease: an open label, uncontrolled, multi-centre trial Journal of Ayub Medical College Abbottabad: Jamc 24(3-4): 14-16
Cañete, R.; Rivas, D.E.; Escobedo, A.A.; González, M.E.; Almirall, P.; Brito, K. 2010: A randomized, controlled, open-label trial evaluating the efficacy and safety of chloroquine in the treatment of giardiasis in children West Indian Medical Journal 59(6): 607-611
Rossi, P.; Fiermonte, G.; Pierelli, F. 2003: Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial Functional Neurology 18(3): 155-159
Kothare, P.A.; Seger, M.E.; Northrup, J.; Mace, K.; Mitchell, M.I.; Linnebjerg, H. 2012: Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial Bmc Clinical Pharmacology 12: 8
Bracken, H.; Dabash, R.; Tsertsvadze, G.; Posohova, S.; Shah, M.; Hajri, S.; Mundle, S.; Chelli, H.; Zeramdini, D.; Tsereteli, T.; Platais, I.; Winikoff, B. 2014: A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial Contraception 89(3): 181-186
Bracken, H.; Dabash, R.; Tsertsvadze, G.; Posohova, S.; Shah, M.; Hajri, S.; Mundle, S.; Chelli, H.; Zeramdini, D.; Tsereteli, T.; Platais, I.; Winikoff, B. 2014: A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label trial Contraception 89(3): 181-186
Kumar, S.; Golla, R.; Bhalla, A.; Sharma, N.; Varma, S. 2020: 0.9% Saline v/s Ringer's Lactate for fl uid resuscitation in adult sepsis patients in emergency medical services: An open label Randomized Controlled trial Journal of the Association of Physicians of India 68(1): 87
Flanagan, K.H.; Glaser, D.A. 2009: An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis Journal of Drugs in Dermatology: Jdd 8(5): 477-480
Gómez, B.J.; Caunedo, A.; Redondo, L.; Esteban, J.; Sáenz-Dana, M.; Blasco, M.; Hergueta, P.; Rodríguez-Téllez, M.; Romero, R.; Pellicer, F.J.; Herrerías, J.M. 2006: Modification of pepsinogen I levels and their correlation with gastrointestinal injury after administration of dexibuprofen, ibuprofen or diclofenac: a randomized, open-label, controlled clinical trial International Journal of Clinical Pharmacology and Therapeutics 44(4): 154-162
Klement, E.; Pitché, P.; Kendjo, E.; Singo, Aétina.; D'Almeida, Séphane.; Akouete, F.; Akpaloo, Y.; Tossa, K.; Prince-Agbodjan, S.; Patassi, A.; Caumes, E. 2014: Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 58(5): 651-659
Homsy, J.; Dorsey, G.; Arinaitwe, E.; Wanzira, H.; Kakuru, A.; Bigira, V.; Muhindo, M.; Kamya, M.R.; Sandison, T.G.; Tappero, J.W. 2014: Protective efficacy of prolonged co-trimoxazole prophylaxis in HIV-exposed children up to age 4 years for the prevention of malaria in Uganda: a randomised controlled open-label trial Lancet. Global Health 2(12): E727-E736
Chetchotisakd, P.; Anunnatsiri, S.; Wankun, J.; Mootsikapun, P.; Boonyaprawit, P. 2002: A randomized, open-label, comparative trial of BID and TID dosing of saquinavir enhanced oral formulation as part of a triple therapy for advanced AIDS patients Journal of the Medical Association of Thailand 85(5): 590-596
Kasserra, C.; Li, J.; March, B.; O'Mara, E. 2011: Effect of vicriviroc with or without ritonavir on oral contraceptive pharmacokinetics: a randomized, open-label, parallel-group, fixed-sequence crossover trial in healthy women Clinical Therapeutics 33(10): 1503-1514
Gordon, J.; Udeh, U.; Doobay, K.; Magro, C.; Wildman, H.; Davids, M.; Mersten, J.N.; Huang, W.-T.; Lyman, S.; Crow, M.K.; Spiera, R.F. 2014: Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 24-month open label, extension phase, single-centre trial Clinical and Experimental Rheumatology 32(6 Suppl 86: S